Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy

References

• Anselmo AC, Mitragotri S. (2014). Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. J Control Release 190:531–41.
   PubMed Web of Science ®Google Scholar
• Barua S, Mitragotri S. (2014). Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today 9:223–43.
   PubMed Web of Science ®Google Scholar
• Brynskikh AM, Zhao Y, Mosley RL. (2010). Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine 5:379–396.
   PubMed Web of Science ®Google Scholar
• Cheema TA, Fecci PE, Ning J, et al. (2014). Immunovirotherapy for the treatment of glioblastoma. Oncoimmunology 3:e27218.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L. (2012). Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev 64:640–65.
   PubMed Web of Science ®Google Scholar
• Dizon DS, Krilov L, Cohen E. (2016). Clinical Cancer Advances 2016: annual report on progress against cancer from the American Society of Clinical Oncology. JCO 34:987–1011.
   PubMed Web of Science ®Google Scholar
• Fleige G, Nolte C, Synowitz M, et al. (2001). Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3:489–99.
   PubMed Web of Science ®Google Scholar
• Floyd JA, Galperin A, Ratner BD. (2015). Drug encapsulated polymeric microspheres for intracranial tumor therapy: a review of the literature. Adv Drug Deliv Rev 91:23–37.
   PubMed Web of Science ®Google Scholar
• Fu J, Wang D, Mei D, et al. (2015). Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. J Control Release 204:11–9.
   PubMed Web of Science ®Google Scholar
• Ge Z, Liu S. (2013). Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance. Chem Soc Rev 42:7289–325.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Suresh P, Zhao Y, et al. (2012). Blood-borne macrophage-neural cell interactions hitchhike endosome networks for cell-based nanozyme brain delivery. Nanomedicine 7:815–33.
   PubMed Web of Science ®Google Scholar
• Jaczewska J, Abdulreda MH, Yau CY, et al. (2014). TNF-α and IFN-γ promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration. J Leukoc Biol 95:265–74.
   PubMed Web of Science ®Google Scholar
• Jinushi M, Komohara Y. (2015). Tumor-associated macrophages as an emerging target against tumors: creating a new path from bench to bedside. Biochim Biophys Acta 1855:123–30.
   PubMed Web of Science ®Google Scholar
• Juratli TA, Schackert G, Krex D. (2013). Current status of local therapy in malignant gliomas-a clinical review of three selected approaches. Pharmacol Ther 139:341–58.
   PubMed Web of Science ®Google Scholar
• Kelly PM, Davison RS, Bliss E, et al. (1988). Macrophages in human breast disease: a quantitative immunohistochemical study. Br J Cancer 57:174–7.
   PubMed Web of Science ®Google Scholar
• Klyachko NL, Haney MJ, Zhao Y, et al. (2014). Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. Nanomedicine (Lond) 9:1403–22.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Masumoto J, Tada T, et al. (2007). Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas. Clin Cancer Res 13:3868–74.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2014). Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2–14.
   PubMed Web of Science ®Google Scholar
• Kroner A, Greenhalgh AD, Zarruk JG, et al. (2014). TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 83:1098–1116.
   PubMed Web of Science ®Google Scholar
• Lasek W, Zagozdzon R. (2017). Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology. Anticancer research 3 :373.
   Google Scholar
• Martinez FO, Gordon S. (2014). The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep 6:13.
   PubMedGoogle Scholar
• Noy R, Pollard JW. (2014). Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:49–61.
   PubMed Web of Science ®Google Scholar
• Owen JL, Mohamadzadeh M. (2013). Macrophages and chemokines as mediators of angiogenesis. Front Physiol 4:159.
   PubMed Web of Science ®Google Scholar
• Pang L, Qin J, Han L, et al. (2016). Exploiting macrophages as targeted carrier to guide nanoparticles into glioma. Oncotarget 7:37081–91.
   PubMed Web of Science ®Google Scholar
• Papa S, Ferrari R, Paola MD, et al. (2014). Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury. J Controlled Release 174:15–26.
   PubMed Web of Science ®Google Scholar
• Parodi A, Quattrocchi N, Ven ALVD, et al. (2013). Biomimetic functionalization with leukocyte membranes imparts cell like functions to synthetic particles. Nature Nanotech 8:61–8.
   PubMed Web of Science ®Google Scholar
• Pei Y, Yeo Y. (2015). Drug delivery to macrophages: Challenges and opportuniies. Journal of Controlled Release Official Journal of the Controlled Release Society 240: 202–211.
   PubMed Web of Science ®Google Scholar
• Penberthy TW, Jiang Y, Graves DT. (1997). Leukocyte adhesion molecules. Crit Rev Oral Biol Med 8:380–8.
   PubMedGoogle Scholar
• Peng Z, Fang S, Liu S, et al. (2016). Anti-PEG antibodies in the clinic: current issues and beyond PEGylation. J Control Release 244:184–93.
   PubMed Web of Science ®Google Scholar
• Qian BZ, Pollard JW. (2010). Macrophage diversity enhances tumor progressio and metastasis. Cell 141:39–51.
   PubMed Web of Science ®Google Scholar
• Qin J, Chen D, Hu H, et al. (2007). Body distribution of RGD-mediated liposome in brain-targeting drug delivery. Yakugaku Zasshi 127:1497–501.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Koo H, Sun IC, et al. (2012). Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy. Adv Drug Deliv Rev 64:1447–58.
   PubMed Web of Science ®Google Scholar
• Sadhukha T, O'Brien TD, Prabha S. (2014). Nano-engineered mesenchymal stem cells as targeted therapeutic carriers. J Control Release 196:243–51.
   PubMed Web of Science ®Google Scholar
• Sawawejksza K, Kandeferszerszeń M. (2017). Tumor-Associated Macrophages as Target for Antitumor Therapy. Arch Immunol Ther Exp 66:97–111.
   PubMed Web of Science ®Google Scholar
• Shiraishi K, Hamano M, Ma H, et al. (2013). Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J Control Release 165:183–90.
   PubMed Web of Science ®Google Scholar
• Solinas G, Germano G, Mantovani A, et al. (2009). Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065–73.
   PubMed Web of Science ®Google Scholar
• Sutton NR, Baek A, Pinsky DJ. (2014). Endothelial cells and inflammation. Encyclopedia Med Immunol 367:381.
   Google Scholar
• Tao Y, Ning M, Dou H. (2013). A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery. Nanomedicine 9:222–32.
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, et al. (2007). Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm 66:488–92.
   PubMed Web of Science ®Google Scholar
• Verhoef JJF, Carpenter JF, Anchordoquy TJ, et al. (2014). Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discov Today 19:1945–52.
   PubMed Web of Science ®Google Scholar
• Vestweber D. (2015). How leukocytes cross the vascular endothelium. Nat Rev Immunol 15:692–704.
   PubMed Web of Science ®Google Scholar
• Wong D, Prameya R, Dorovini-Zis K. (2007). Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. J Neuroimmunol 184:136–48.
   PubMed Web of Science ®Google Scholar
• Zhang C, Ling C-l, Pang L, et al. (2017). Direct macromolecular drug delivery to cerebral ischemia area using neutrophil-mediated nanoparticles. Theranostics 7:3260–75.
   PubMed Web of Science ®Google Scholar